دورية أكاديمية

Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions

التفاصيل البيبلوغرافية
العنوان: Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions
المؤلفون: Silvestri, Giovannino, Trotta, Rossana, Stramucci, Lorenzo, Ellis, Justin J, Harb, Jason G, Neviani, Paolo, Wang, Shuzhen, Eisfeld, Ann-Kathrin, Walker, Christopher J, Zhang, Bin, Srutova, Klara, Gambacorti-Passerini, Carlo, Pineda, Gabriel, Jamieson, Catriona H M, Stagno, Fabio, Vigneri, Paolo, Nteliopoulos, Georgios, May, Philippa C, Reid, Alistair G, Garzon, Ramiro, Roy, Denis-Claude, Moutuou, Moutuaata M, Guimond, Martin, Hokland, Peter, Deininger, Michael W, Fitzgerald, Garrett, Harman, Christopher, Dazzi, Francesco, Milojkovic, Dragana, Apperley, Jane F, Marcucci, Guido, Qi, Jianfei, Polakova, Katerina Machova, Zou, Ying, Fan, Xiaoxuan, Baer, Maria R, Calabretta, Bruno, Perrotti, Danilo
المصدر: Silvestri , G , Trotta , R , Stramucci , L , Ellis , J J , Harb , J G , Neviani , P , Wang , S , Eisfeld , A-K , Walker , C J , Zhang , B , Srutova , K , Gambacorti-Passerini , C , Pineda , G , Jamieson , C H M , Stagno , F , Vigneri , P , Nteliopoulos , G , May , P C , Reid , A G , Garzon , R , Roy , D-C , Moutuou , M M , Guimond , M ....
سنة النشر: 2020
المجموعة: Aarhus University: Research
الوصف: Persistence of drug-resistant quiescent leukemic stem cells (LSC) and impaired natural killer (NK) cell immune response account for relapse of chronic myelogenous leukemia (CML). Inactivation of protein phosphatase 2A (PP2A) is essential for CML-quiescent LSC survival and NK cell antitumor activity. Here we show that MIR300 has antiproliferative and PP2A-activating functions that are dose dependently differentially induced by CCND2/CDK6 and SET inhibition, respectively. MIR300 is upregulated in CML LSCs and NK cells by bone marrow microenvironment (BMM) signals to induce quiescence and impair immune response, respectively. Conversely, BCR-ABL1 downregulates MIR300 in CML progenitors to prevent growth arrest and PP2A-mediated apoptosis. Quiescent LSCs escape apoptosis by upregulating TUG1 long noncoding RNA that uncouples and limits MIR300 function to cytostasis. Genetic and pharmacologic MIR300 modulation and/or PP2A-activating drug treatment restore NK cell activity, inhibit BMM-induced growth arrest, and selectively trigger LSC apoptosis in vitro and in patient-derived xenografts; hence, the importance of MIR300 and PP2A activity for CML development and therapy.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://pure.au.dk/portal/en/publications/5ef7c005-d8c1-4979-95c9-5c23640f75dfTest
DOI: 10.1158/0008-5472.BCD-19-0039
الإتاحة: https://doi.org/10.1158/0008-5472.BCD-19-0039Test
https://pure.au.dk/portal/en/publications/5ef7c005-d8c1-4979-95c9-5c23640f75dfTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510943/pdf/nihms-1623750.pdfTest
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.288108E3
قاعدة البيانات: BASE